Juvaris BioTherapeutics is a new biotechnology company, started in February, 2003, that is developing potent active immunotherapeutic vaccines. Active immunotherapy involves the activation of the patient's own Immune system to combat disease as opposed to passive immunotherapy utilizing administration of preformed monocional antibodies.

Grants & Contracts

The Company has obtained significant funding of its research though grants issued by the NIH. These grants have allowed, through non-dilutive financing, the advancement of many research programs that represent commercial opportunities for the Company.


About Us \| Technology Platform \| Pipeline \| Collaborators \| News & Presentations \| Careers \| Contact \| Site Map \| Home	Terms of Use \| Legal \| Site Users Guide © 2010 Juvaris BioTherapeutics.

© 2010 Juvaris BioTherapeutics.